Unlock instant, AI-driven research and patent intelligence for your innovation.

N139 mutant protein of osteoprotegerin and related products and applications

A technology of osteoprotegerin and mutants, applied in the fields of application, peptide/protein composition, animal/human protein, etc., can solve problems such as increasing tumor risk and affecting clinical application

Active Publication Date: 2021-02-12
北京济全生物科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

One of the reasons is that OPG was found to be defective, which affected its clinical application: the structure of RANKL is similar to tumor necrosis factor related apoptosis-inducing ligand (TRAIL), and the combination of OPG and RANKL At the same time, it can also combine with TRAIL, inhibit the anti-cancer effect of TRAIL, and increase the risk of tumor occurrence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • N139 mutant protein of osteoprotegerin and related products and applications
  • N139 mutant protein of osteoprotegerin and related products and applications
  • N139 mutant protein of osteoprotegerin and related products and applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0107] Example 1. Preparation of wild-type human osteoprotegerin OPGwt and wild-type human osteoprotegerin mutant proteins OPGN139G, OPGN139A, OPGN139V, OPGN139L, OPGE96G and OPGR122G

[0108] 1. Preparation of wild-type human osteoprotegerin OPGwt

[0109] The amino acid sequence of wild-type human osteoprotegerin OPGwt is the 154th to 345th amino acid residues of SEQ ID No.2. Wild-type human osteoprotegerin OPGwt contains amino acid residues 22-201 of human full-length osteoprotegerin (amino acid sequence is GenBank AccessionNumberNP_002537.3 (Update Date: 26-JUN-2017) or SEQ ID No.9)). Wild-type human osteoprotegerin OPGwt was prepared according to the method of the following literature: Mengmeng Jin, et al. Sortase A-aided Escherichia coli expression system for functional osteoprotegerincysteine-rich domain. Appl Microbiol Biotechnol (2017) 101:4923–4933. s00253-017-8188-6. The specific method is as follows:

[0110] 1.1 Preparation of DNA molecules

[0111] The DNA sh...

Embodiment 2

[0168] Example 2, Affinity Determination of Wild-type Human Osteoprotegerin OPGwt and Human Osteoprotegerin Mutant Proteins OPGN139A, OPGN139V, OPGN139G, OPGN139L, OPGE96G and OPGR122G with RANKL and TRAIL

[0169] The surface plasmon resonance (Surface Plasmon Resonance, SPR) technology was used, and the equipment used was BIAcore 3000 (GE Healthcare), and RANKL or TRAIL was used as the stationary phase to immobilize on a certain channel on the surface of the CM5 chip (diluted into 10mM sodium acetate pH5.5 ), the response value increased by about 2000RU; TNFRSF9 was fixed in another channel as an internal reference; the OPGwt prepared in Example 1 and the mutant proteins OPGN139A, OPGN139V, OPGN139G, OPGN139L, OPGE96G and OPGR122G of human osteoprotegerin were used as mobile phases, and BIAcore buffer (10mM HEPES, 150mMNaCl, 0.005% Tween 20, pH 7.4) prepared OPGwt and human osteoprotegerin mutant proteins OPGN139A, OPGN139V, OPGN139G, OPGN139L, OPGE96G and OPGR122G at differe...

Embodiment 3

[0181] Example 3. Biological activities of wild-type human osteoprotegerin OPGwt and mutant proteins OPGN139A, OPGN139V, OPGN139G, OPGN139L, OPGE96G and OPGR122G of human osteoprotegerin

[0182] 1. Inhibition of RANKL-mediated osteoclast activation experiment

[0183] The differentiation and maturation of RANKL-induced osteoclasts are marked by the formation of multinucleated cells and the expression of tartrate-resistant acid phosphatase (TRAP) in multinucleated cells.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a mutant protein of osteoprotegerin and its related products and applications. Compared with the wild-type osteoprotegerin, the mutant protein of the osteoprotegerin has the amino acid residue at position 139 of the full-length sequence of the wild-type osteoprotegerin replaced; the mutant protein has an affinity for RANKL activity but the affinity activity of the mutant protein for TRAIL was lower than that of the wild-type osteoprotegerin. Experiments have shown that compared with the corresponding wild type, the mutant protein of osteoprotegerin of the present invention has no significant difference in the ability to inhibit RANKL-induced osteoclast differentiation, and can overcome the defect of wild type inhibiting the anti-tumor effect of TRAIL, and is more efficient and safe. Play a role in the prevention and treatment of bone resorption-related diseases.

Description

technical field [0001] The invention relates to a mutant protein of osteoprotegerin and related products and applications in the field of biotechnology. Background technique [0002] Bone resorption-related diseases represented by osteoporosis and arthritis are common and frequently-occurring diseases in the world, which have seriously affected human health. The pathological feature of bone resorption-related diseases is bone resorption-formation imbalance, and the most important signal transduction pathway regulating bone resorption and formation balance has been proved to be the OPG / RANKL / RANK system. In this system, osteoprotegerin (Osteoprotegerin, OPG) plays a vital role as the central link. [0003] In 1997, two research groups in the United States and Japan discovered the OPG protein at the same time. It belongs to the TNF receptor superfamily member. It is a soluble and secreted glycoprotein consisting of 401 amino acids. It is expressed in osteoblasts / bone mesench...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/705C07K19/00C12N15/12C12N5/10A61K38/17A61P19/08
CPCA61K38/00C07K14/70578C07K2319/30C07K2319/31
Inventor 王玮
Owner 北京济全生物科技有限公司